Ovarian cancer: update on serum biomarkers

A review of the NICE guideline on ovarian cancer has identified new evidence related to the diagnostic accuracy of serum tumour marker HE4 and the ROMA score, resulting in a decision to update advice on what serum tumour marker tests should be carried out routinely to aid diagnosis.

You need to be logged in to read the rest of this story. If you are not already a member, please register with us completely free of charge.
 

Other news

Upcoming Events

UK NEQAS: Coordinating Point-of-Care Testing

Queen Elizabeth II Conference Centre, Broad Sanctuary, Westminster, London SW1 3EE
20 October 2017

British Association for Cytopathology

National Railway Museum, York
4 November 2017

Biosafety Practitioner Level 1 Training Course

Public Health England
15-19 January 2018

British Society for Microbial Technology Annual Scientific Conference

Public Health England, Colindale, London
18 May 2018

Microbe 2018

Hilton Hotel, Sheffield
21-23 September 2018

Latest Issue

Pathology In Practice

Pathology In Practice

Aug 2017

Screening for haemoglobinopathies

Register now to apply for regular copies of Pathology In Practice and free access to premium content, as well as our regular newsletters.